FDA approves Gardasil vaccine to prevent cervical cancer
The FDA approves Merck's Gardasil for girls and women ages 9 to 26 to protect against four HPV strains. It blocks two cancer-causing strains and two wart-related strains, with trials showing up to 100 percent cervical cancer prevention for uninfected women and 99 percent wart prevention. Availability by year end with debate over cost, booster needs, and school-mandatory use.
MENTIONED IN THIS ARTICLE
Washington
Food and Drug Administration
United States
FDA
Andrew von Eschenbach
Merck & Co. Inc
Merck
Alex Azar
Jesse Goodman
Agency
Center For Biologics and
U.S
Also Mentioned on This Page
John Keating
John KE
Kelli Sullivan
Sterling Valedictorian
Bradley Kohles
Sterling Salutatorian
Michael Bartrip
Lee Valedictor
Jennifer Branham
Lee Salutatorian
Lee
Aurora Villegas
Dinora Gisell Sanchez
Vanessa Snodgrass
Brian DonCarlos
Christina Staples
Jared Bruner
AnnElisa Stanley
Crystal Huerta
Chevy Avalanche
Tin
Johnkeatingchevy.com
ABC
Una Crosby
Texas
John Kfa
Richard Clark
Cynthia Dailard
Guttmacher Institute
Fusion
Franklin Ford
X-Plan
Hunters
Mustang